Introduction:
Ribosome pool engineering has the potential to revolutionize the bioeconomy by significantly improving protein synthesis yields and reducing drug manufacturing costs, according to recent research from Northwestern University and Stanford University. By customizing ribosome pools to maximize the expression of specific proteins, this new approach offers a novel way to enhance biomanufacturing and synthetic biology applications.
- Sequence differences in ribosomal RNA operons in Escherichia coli can lead to functional changes in protein synthesis abilities.
- Some ribosomal RNA operons cause significant functional changes in ribosomes, such as reducing their translation ability.
- Using a single operon for protein synthesis yielded better results than a heterologous pool of ribosomes.
- One specific operon, operon A rRNA, increased protein production by almost three-fold.
- Ribosomes derived from one of the ribosomal RNA operons were essentially nonfunctional, indicating that the ribosome pool could be strengthened by replacing weaker variants.
Conclusion:
Ribosome pool engineering has the potential to optimize bioengineering and biomanufacturing processes by manipulating the ribosome sequences in biomanufacturing strains. By customizing ribosome pools to maximize protein synthesis yields, this approach can pave the way for improved drug manufacturing efficiency and advancement in the bioeconomy.
